eScholarshipmetadata only
A genetically engineered microRNA-34a prodrug demonstrates anti-tumor activity in a canine model of osteosarcoma
32 biomedical and clinical sciences (for-2020), 3404 medicinal and biomolecular chemistry (for-2020), 34 chemical sciences (for-2020), genetics (rcdc), biotechnology (rcdc), bioengineering (rcdc), pediatric research initiative (rcdc), pediatric cancer (rcdc)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 1038704
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.